Klotho Neurosciences Stock Price, News & Analysis
Company Description
Klotho Neurosciences (NASDAQ: KLTOW) is a publicly traded company in the Biological Products, (no Diagnostic Substances) sector.
KLTOW stock has gained 203.9% over the past year. Shares last traded at $0.0860.
On a trailing twelve-month basis, Klotho Neurosciences reported net income of -$6.2M and diluted earnings per share of $-0.32.
This page provides a comprehensive overview of KLTOW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Klotho Neurosciences (KLTOW) stock last traded at $0.0860. Over the past 12 months, the stock has gained 203.9%.
Latest News
SEC Filings
Klotho Neurosciences has filed 5 recent SEC filings, including 3 Form 8-K, 1 Form 10-K, 1 Form SCHEDULE 13G. The most recent filing was submitted on April 1, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all KLTOW SEC filings →
Financial Highlights
operating income reached -$5.5M, and net income was -$6.2M. Diluted earnings per share stood at $-0.32. The company generated -$2.9M in operating cash flow. With a current ratio of 0.13, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Klotho Neurosciences (KLTOW) currently stands at 58.6 thousand shares, up 20.2% from the previous reporting period. Over the past 12 months, short interest has increased by 248.1%.
Days to Cover History
Days to cover for Klotho Neurosciences (KLTOW) currently stands at 4.7 days. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The ratio has shown significant volatility over the period, ranging from 1.0 to 9.6 days.
KLTOW Company Profile & Sector Positioning
Klotho Neurosciences (KLTOW) operates in the Biological Products, (no Diagnostic Substances) sector and is listed on the NASDAQ.